A new in vitro model for studying human T cell differentiation: T(H1)/T(H2) induction following activation by superantigens

Journal of Immunological Methods

Volumn 219, Issue 1-2, 1998, Pages 85-98

  Gehring, Svante ^a   Schlaak, Max ^a   Van Der Bosch, Jürgen ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

Author keywords

Flow cytometry; In vitro model; Intracellular cytokines; Serum free medium; Superantigens; T cell differentiation; Th1 Th2

Indexed keywords

SUPERANTIGEN;

ALLERGY; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DRUG SCREENING; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

BACTERIAL TOXINS; CELL DIFFERENTIATION; CELL SEPARATION; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; ENTEROTOXINS; EXOTOXINS; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; INTERLEUKINS; LYMPHOCYTE ACTIVATION; NEURAMINIDASE; PENTOXIFYLLINE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, INTERLEUKIN-2; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; TH1 CELLS; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA; VITAMIN D;

EID: 0032190979     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(98)00142-2     Document Type: Article

References (39)

1. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature. 383:1996;787.
2. Allen J.E., Maizels R.M. Th1-Th2: reliable paradigm or dangerous dogma? Immunol. Today. 18:1997;387.
3. Breit S., Steinhoff M., Blaser K., Heusser C.H., Sebald W., Levine A.D., Röcken M. A strict requirement of interleukin-4 for interleukin-4 induction in antigen-stimulated human memory T cells. Eur. J. Immunol. 26:1996;1860.
4. Brennan F.M., Feldmann M. Cytokines in autoimmunity. Curr. Opin. Immunol. 8:1996;872.
5. + T cell lines. J. Exp. Med. 185:1997;1769.
6. Chen X.-P., Enioutina E.Y., Daynes R.A. The control of IL-4 gene expression in activated murine T lymphocytes. A novel role for neu-1 sialidase. J. Immunol. 158:1997;3070.
7. Choi Y., Kotzin B., Herron L., Callahan J., Marrack P., Kappler J. Interaction of staphylococcus aureus toxin 'superantigens' with human T cells. Proc. Natl. Acad. Sci. U.S.A. 86:1989;8941.
8. Croft M., Dubey C. Accessory molecule and costimulation requirements for CD4 T cell response. Crit. Rev. Immunol. 17:1997;89.
9. De Vries J.E., Carballido J.M., Sornasse T., Yssel H. Antagonizing the differentiation and functions of human T helper type 2 cells. Curr. Opin. Immunol. 7:1995;771.
10. Duez C., Tsicopoulos A., Janin A., Tillie-Leblond I., Thyphronitis G., Marquillies P., Hamid Q., Wallaert B., Tonnel A.-B., Pestel J. An in vivo model of allergic inflammation: pulmonary human cell infiltrate in allergen-challenged allergic Hu-SCID mice. Eur. J. Immunol. 26:1996;1088.
11. lck and ZAP-70 tyrosine kinase activities. J. Immunol. 159:1997;53.
12. Fleischer B., Necker A., Leget C., Malissen B., Romagne F. Reactivity of mouse T-cell hybridomas expressing human Vbeta gene segments with staphylococcal and streptococcal superantigens. Infect. Immun. 64:1996;987.
13. Goldstone S.D., Hunt N.H. Redox regulation of the mitogen-activated protein kinase pathway during lymphocyte activation. Biochim. Biophys. Acta. 1355:1997;353.
14. Gonzalo J.-A., Lloyd C.M., Kremer L., Finger E., Martinez-A C., Siegelman M.H., Cybulsky M., Gutierrez-Ramos J.-C. Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. J. Clin. Invest. 98:1996;2332.
15. Li Y., Simons E.R., Jay F.T., HayGlass K.T. Allergen-driven limiting dilution analysis of human IL-4 and IFN-γ production in allergic rhinitis and clinically tolerant individuals. Int. Immunol. 8:1996;897.
16. Moller D.R., Wysocka M., Greenlee B.M., Ma X., Wahl L., Trinchieri G., Karp C.L. Inhibition of human interleukin-12 production by pentoxifylline. Immunology. 91:1997;197.
17. Mosmann T.R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today. 17:1996;138.
18. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone: I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:1986;2348.
19. Nicholson L.B., Kuchroo V.K. Manipulation of the Th1/Th2 balance in autoimmune disease. Curr. Opin. Immunol. 8:1996;837.
20. Ohshima Y., Delespesse G. T cell-derived IL-4 and dendritic cell-derived IL-12 regulate the lymphokine-producing phenotype of alloantigen-primed naive human CD4 T cells. J. Immunol. 158:1997;629.
21. Palm N., Germann T., Goedert S., Hoehn P., Koelsch S., Rüde E., Schmitt E. Co-development of naive CD4+ cells towards T helper type 1 or T helper type 2 cells induced by a combination of IL-12 and IL-4. Immunobiology. 196:1997;475.
22. H1 cells. Science. 269:1995;245.
23. Pfeiffer C., Stein J., Southwood S., Ketelaar H., Sette A., Bottomly K. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181:1995;1569.
24. Picker L.J., Singh M.K., Zdraveski Z., Treer J.R., Waldrop S.L., Bergstresser P.R., Maino V.C. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood. 86:1995;1408.
25. 3 inhibits γ-interferon synthesis by normal human peripheral blood lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 84:1987;3385.
26. + T cells. J. Exp. Med. 185:1997;461.
27. Rink L., Nicklas W., Alvarez-Ossorio L., Fagin U., Kirchner H. Microbial superantigens stimulate T cells by the superantigen bridge and independently by a cytokine pathway. J. Interferon Cytokine Res. 17:1997;489.
28. Rogge L., Barberis-Maino L., Biffi M., Passini N., Presky D.H., Gubler U., Sinigaglia F. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185:1997;825.
29. Romagnani S. The Th1/Th2 paradigm. Immunol. Today. 18:1997;263.
30. Röcken M., Urban J., Shevach E.M. Antigen-specific activation, tolerization, and reactivation of the interleukin 4 pathway in vivo. J. Exp. Med. 179:1994;1885.
31. Scott P. IL-12: initiation cytokine for cell-metiated immunity. Science. 260:1993;48.
32. Seder R.A., Prussin C. Are differentiated human T helper cells reversible? Int. Arch. Allergy Immunol. 113:1997;163.
33. + T cells, analyzed at the single-cell level. J. Exp. Med. 184:1996;473.
34. + cells in the pathogenesis of allergic disease. P.S.E.B.M. 215:1997;11.
35. Upham J.W., Holt B.J., Baron-Hay M.J., Yabuhara A., Hales B.J., Thomas W.R., Loh R.K.S., O'Keeffe P.T., Palmer L., Le Souef P.N., Sly P.D., Burton P.R., Robinson B.W.S., Holt P.G. Inhalant allergen-specific T-cell reactivity is detectable in close to 100% of atopic and normal individuals: covert responses are unmasked by serum-free medium. Clin. Exp. Allergy. 25:1995;634.
36. Valitutti S., Müller S., Salio M., Lanzavecchia A. Degradation of T cell receptor (TCR)-CD3-ζ complexes after antigenic stimulation. J. Exp. Med. 185:1997;1859.
37. Van der Bosch J., Rüller S., Horn D., Schumann R., Schlaak M. Density-dependent tumor cell death and reversible cell cycle arrest: mutually exclusive modes of monocyte-mediated growth control. Exp. Cell Res. 187:1990;185.
38. Van Neerven R.J.J., Ebner C., Yssel H., Kapsenberg M.L., Lamb J.R. T-cell responses to allergens: epitope-specificity and clinical relevance. Immunol. Today. 17:1996;526.
39. Weiner H.L. Oral tolerance: immune mechanisms and treatment of autoimmune disease. Immunol. Today. 18:1997;335.